Vol 5 Issue 2

IMMUNO-ONCOLOGY INSIGHTS

March 2024 Issue

Vol 5 Issue 2

Download PDF

Featuring

Issue Spotlight: Combination therapy development
Practical Considerations for Cutting Edge Tech 2024
Other articles

SPOTLIGHT

Combination therapy development

Interview

The evolving landscape of combination therapies in lung cancer

The evolving landscape of combination therapies in lung cancer

Heather Wakelee
25 March
Read
Developing novel radio immunotherapy combinations for lung cancer treatment

Developing novel radio immunotherapy combinations for lung cancer treatment

Joe Chang
12 March
Read
Combination therapies: a journey into personalized vaccine immunotherapeutics for early-stage cancers

Combination therapies: a journey into personalized vaccine immunotherapeutics for early-stage cancers

Stephen Johnston
6 March
Read
Advancing combination therapies: a discussion on trials, challenges, and future goals

Advancing combination therapies: a discussion on trials, challenges, and future goals

Aakash Desai
22 February
Read

Viewpoint

Exploring the potential of combination radio-immunotherapy for a comprehensive cancer treatment

Exploring the potential of combination radio-immunotherapy for a comprehensive cancer treatment

Zachary Morris
4 April
Read
Unraveling combination therapies in lung cancer: oncogenic drivers, ICI resistance, and predictive biomarkers

Unraveling combination therapies in lung cancer: oncogenic drivers, ICI resistance, and predictive biomarkers

Paul Hofman
27 March
Read

Tools & Technologies FOCUS

Practical Considerations for Cutting Edge Tech 2024

Interview

A deep dive into generative AI applications in I-O

A deep dive into generative AI applications in I-O

André Freitas
12 March
Read

Journal articles

FastFacts

Myeloid cells: unveiling their secrets as biomarkers through next-generation sample preparation

Myeloid cells: unveiling their secrets as biomarkers through next-generation sample preparation

Chyan Ying Ke
25 March
Read